NCT04781972View on ClinicalTrials.gov

Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD

PHASE4RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 27, 2021

Primary Completion Date

November 30, 2028

Study Completion Date

April 30, 2029

Conditions
ADHD - Combined Type
Interventions
DRUG

Methylphenidate

single dose of 10 mg or 15 mg

DRUG

Placebo

Matching placebo

Trial Locations (1)

21205

RECRUITING

Johns Hopkins School of Medicine, Baltimore

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Johns Hopkins University

OTHER